Press Releases

INDIANAPOLIS and MENLO PARK, Calif., Jan. 10, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Dermira, Inc. (NASDAQ: DERM) today announced a definitive agreement for Lilly to acquire Dermira for $18.75 per share, or approximately $1.1 billion, in an all-cash transactio

TUCSON, Ariz., Jan. 10, 2020 /PRNewswire/ -- Amy Di Lillo Yoga hosts Brain Longevity Seminar Series with all proceeds going to The Alzheimer's Research and Prevention Foundation (ARPF).Yoga Therapist and Brain Longevity Specialist Amy Di Lillo, C-IAYT, E-RYT, YACEP will be hosting a three-part Brain Longevity Series cover

SOUTH SAN FRANCISCO, Calif., Jan. 10, 2020 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced that the company has entered into a Sponsored Research Agreement with Boston Children's Hospital for preclinical evaluation of the role of protein k

ÖSTERSUND, Sweden, Jan. 10, 2020 /PRNewswire/ -- Skanska has signed a contract with North Shore University Hospital (NSUH) to construct the new advanced surgical pavilion at their campus in Manhasset, New York, USA. The contract is worth USD 238 M, about SEK 2.3 billion,

PARIS and BOSTON, Jan. 10, 2020 /PRNewswire/ -- Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, today announced that it has secured 

MOUNTAIN VIEW, Calif., Jan. 10, 2020 /PRNewswire/ -- MedLever announced that it has signed an agreement with RaySearch Laboratories to develop interoperability and advance workflow automation solutions in cancer care.  The interoperability will support streamlined task management and simplify clinical workflow between RayStation, RayCare and the MedLever Platform.

SAN DIEGO and ALLSCHWIL, Switzerland, Jan. 10, 2020 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) and Idorsia Ltd. (SIX: IDIA) announced an amendment to the agreement that was originally signed in 2019 granting Neurocrine Biosciences an option to license ACT-709478, a potent, selective, orally-active, and brain penetrating T

SAN DIEGO, Jan. 9, 2020 /PRNewswire/ -- Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced the pricing of an underwritten public offering of 3,076,924 shares of its common stock at a price to the public of $97.50 per share. The aggregate gross proceeds from this offering are expected to be approximately $300

TAIPEI, Jan. 9, 2020 /PRNewswire/ -- Asia Agri-Tech Expo & Forum 2020 changes its dates for new labour policies at Taipei Nangang Exhibition Center, Hall 1 from 5th to 7th November 2020, and will be co-located with Aquaculture Taiwan and Livestock Taiwan. The 3-in-1 event has moved one day ahead of previously releas

SCHAUMBURG, Ill., Jan. 9, 2020 /PRNewswire/ -- The American Veterinary Medical Association (AVMA) Board of Directors today approved a $25,000 donation to aid Australian veterinarians who are helping animals impacted by the bushfires ravaging their country. In addition, the AVMA is encouraging its 95,000 members and the general public to cons